TG Therapeutics Inc logo

TG Therapeutics Inc

NEW
FRA:NKB2 (USA)   Ordinary Shares
€ 51 +0.80 (+1.59%) Jul 10
19.97
P/B:
15.00
Market Cap:
€ 7.68B ($ 8.78B)
Enterprise V:
€ 7.89B ($ 9.02B)
Volume:
200.00
Avg Vol (2M):
483.00
Trade In:

TG Therapeutics Inc Valuation Measures